Kyungpook National University Chilgok Hospital

Daegu, Gyeongsangbukdo 41404

0 studies enrolling now · 4 studies all time

What they study most

Gastric Cancer, Gastric, or Gastroesophageal Junction Adenocarcinoma, Limited Stage Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed
• Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer — Completed
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed